Salvage yard.

The recently-reported RADICALS-RT trial suggests early-salvage for biochemically-recurrent prostate cancer is a good strategy. So how many people are employing it? Of >1K patients in a Michiganian prospective surgical cohort with detectable post-op PSA, less than a third received salvage radiation. The biggest predictor was—you guessed it—practice where the patient was receiving care, with some offering it 73% of the time and some only 7% of the time. | Hawken, Int J Radiat Oncol Biol Phys 2019